...
首页> 外文期刊>Journal of liquid chromatography and related technologies >Robotic Sample Preparation and HPLC Determination of the Major Component of Ivermectin in Human Plasma
【24h】

Robotic Sample Preparation and HPLC Determination of the Major Component of Ivermectin in Human Plasma

机译:机器人样品制备和高效液相色谱法测定人血浆中伊维菌素的主要成分

获取原文
获取原文并翻译 | 示例

摘要

A robotic sample preparation method combined with high performance liquid chromatography (HPLC)-fluorescence detection for the determination of the major component of ivermectin in human plasma is presented. A Cyberlab C-300 workstation equipped with customized software and hardware was utilized to perform all the semi-automated liquid-solid phase extraction (LSPE) steps including acetonitrile (ACN) and water addition, sample loading, and hexane elution on Chem Elut~(TM) cartridges. Under the automated pre-colmn derivatization conditions, both ivermectin and internal standard of the extracted samples were chemically converted to highly fluorescent derivatives and then monitored by a fluorescence detector. The assay was validated in the concentration range of 0.5-40 ng/mL, using 1 mL of human plasma. The application of this assay was demonstrated by analysis of plasma samples from human subjects receiving oral doses of ivermectin.
机译:提出了一种结合高效液相色谱(HPLC)-荧光检测的机器人样品制备方法,用于测定人血浆中伊维菌素的主要成分。利用配备有定制软件和硬件的Cyber​​lab C-300工作站来执行所有半自动化的液相-固相​​萃取(LSPE)步骤,包括乙腈(ACN)和加水,样品上样以及在Chem Elut上进行己烷洗脱TM)墨盒。在自动菌落前衍生条件下,伊维菌素和提取样品的内标均被化学转化为高荧光衍生物,然后通过荧光检测器进行监测。使用1 mL人血浆在0.5-40 ng / mL的浓度范围内验证了该测定法。该分析的应用通过分析接受口服伊维菌素的人类受试者的血浆样品进行了分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号